Endonovo Therapeutics, Inc.

Research, Biotechnology, Life sciences, Research, Biotechnology research
Founded in 2011
Los Angeles, California
http://www.endonovo.com
None

About Endonovo Therapeutics, Inc.

Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. Endonovo's Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. Endonovo's Cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 11.2M None
  • Last Funding: 225K None (None)
  • Funding Status: None

Technology Stack

Endonovo Therapeutics, Inc. actively uses None products in their tech stack.

Market Presence

Industries: Research, Biotechnology, Life sciences, Research, Biotechnology research

Headquarters: Los Angeles, California